Technology
AB Science Receives Notice Of Allowance For European Patent Covering Masitinib Until 2040 In The Treatment Of Sickle Cell Disease
(MENAFN - GlobeNewsWire - Nasdaq) PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE THIS ...
By: menafn
- Oct 29 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS